“Blockbuster injections such as Wegovy have revolutionised the treatment of obesity, and recently been approved for use in other areas of medicine, including reducing the risk of heart attacks, strokes and cardiovascular-related deaths.

Now experts say they increasingly believe weight-loss drugs could play a big role in preventing and treating cancer, the second leading cause of deaths globally.

A study presented at the world’s largest cancer conference found patients taking the drugs were 19% less likely to develop 13 obesity-related cancers, including ovarian, liver, colorectal, pancreatic, bowel and breast cancer.

The research involving 34,000 people, led by the Case Western Reserve University in Ohio, also found patients were half as likely to die over 15 years compared with patients not taking the jabs, also known as GLP-1 receptor agonists (RA).”

From The Guardian.